Matthew Yeowart
Lawyers
Filters
Nuvei $6.3 billion going-private acquisition
We are advising Nuvei on the transaction
MSCI acquisition of Foxberry
We are advising MSCI on the acquisition
Bridgepoint sale of a minority interest in Humanetics
We are advising Bridgepoint and Humanetics on the transaction
Cubic Telecom €473 million strategic investment by SoftBank
We are advising Cubic Telecom on the strategic investment
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Instant Brands sale of substantially all of its assets to Centre Lane Partners
We are advising Instant Brands on the sale
Orogen Group investment in Brillio
We advised the Orogen Group on the investment
Diebold Nixdorf emerges from chapter 11 and WHOA and obtains chapter 15 recognition
We advised an ad hoc group of secured creditors in connection with Diebold’s restructuring proceedings
Lucid Group $232 million strategic supply agreement with Aston Martin
We are advising Lucid Group on the transaction